Background Measles remains a major public health concern in Nigeria, contributing disproportionately to the global burden. Persistence of the disease is driven by sub-optimal vaccination coverage and heterogeneous transmission patterns, but the specific spatio-temporal dynamics and the quantitative impact of vaccination gaps at the sub-national level are not fully characterized. Objective This study aimed to provide a comprehensive analysis of measles transmission in Nigeria from 2006 to 2025, with the specific objectives to identify spatial hotspots, quantify their temporal persistence, and evaluate the association between MCV1/MCV2 coverage and measles case ratio. Methods We conducted a national retrospective ecological study, integrating 19 years of surveillance data (2006–2025) and geospatial information, with a focused 4-year analysis of vaccination records (2021–2024). Analytical methods included time-series decomposition, spatial autocorrelation (Local Moran’s I and Getis-Ord Gi*), and linear mixed-effects modeling to quantify vaccination effects while accounting for state-level heterogeneity. Results Analysis of 253,595 measles cases revealed a highly clustered geographic distribution, with 86.4% of the national burden concentrated in northern Nigeria. We identified 38 persistent hotspot Local Government Areas that accounted for 23.2% of all cases. Vaccination coverage was low and disparate, with national averages of 73.8% for MCV1 and 38.4% for MCV2. Mixed-effects modeling confirmed a significant negative association between MCV1 coverage and the measles case ratio, while MCV2 coverage did not show a statistically significant independent effect. Conclusion Measles transmission in Nigeria is driven by entrenched hotspots in the north and critical vaccination gaps threatening disease resurgence in the south. Achieving elimination requires a tailored strategy: intensive supplemental immunization activities and RI strengthening aimed at reducing endemic transmission in the northern hotspots, coupled with focused efforts to close routine immunization gaps in specific southern states.
No takes yet. Share an insight, caveat, or question.
Ezenwa-Ahanene et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: